Publications (21 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.* Toomer KH et al. (2023) SARS-CoV-2 infection results in upregulation of Plasminogen Activator Inhibitor-1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity. EJHaem. 4(2):324-338.
* Vitalievna SE (2021) Indicators of Endothelial dysfunction and factors hemostasis in patients with stable and unstable atherosclerotic plaques. Scientific Research Institute of therapy and preventive medicine. Thesis.
* Stryukova EV (2021) Indicator of endothelial dysfunction and factors hemostasis in patients iwht stable and unstable atherosclerotic plates. Federal Research Center Institue of Cytology and Genetics of the Siberian Branch Russian Academy of Sciences. Dissertation.
* Kondo A et al. (2021) Measuring serum prothrombin in patients treated with warfarin or direct oral anticoagulants. Clin Chim Acta. 523:224-230.
* Sikora M et al. (2020) Cystathionine beta?synthase defciency: diferent changes in proteomes of thrombosis?resistant Cbs?/? mice and thrombosis?prone CBS?/? humans.
* Premkumar M et al. (2020) Heparin-like Effect Associated With Risk of Bleeding, Sepsis, and Death in Patients With Severe Alcohol-Associated Hepatitis. Clin Gastroenterol Hepatol. 18(2):486-495.e3.
* Ragino YI et al. (2019) Association of some hemostasis and endothelial dysfunction factors with probability of presence of vulnerable atherosclerotic plaques in patients with coronary atherosclerosis. BMC Res Notes. 12(1):336.
* Premkumar M et al. (2019) Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute on chronic liver failure: An observational cohort study. Liver Int. 39(4):694-704
* Nnachi OC et al. (2019) Antithrombin Levels in Adults with Ischaemic Stroke seen at the University of Benin Teaching Hospital, Benin City. J. Res. Basic Clin. Sciences. 1(3).
* Chan KC et al. (2019) Astaxanthin attenuated thrombotic risk factors in type 2 diabetic patients. Journal of Functional Foods. 53:22-27
* Banerjee A et al. (2018) Systemic hyperfibrinolysis after trauma: a pilot study of targeted proteomic analysis of superposed mechanisms in patient plasma. J Trauma Acute Care Surg. 84(6): 929-938.
* Selmeczi A et al. (2017) Antithrombin Debrecen (p. Leu205Pro)?Clinical and molecular characterization of a novel mutation associated with severe thrombotic tendency. Thromb Res. 158:1-7
* Schochl H et al. (2017) Dual inhibition of thrombin and activated factor X attenuates disseminated intravascular coagulation and protects organ function in a baboon model of severe Gram-negative sepsis. Critical Care. 21(1):51
* Nair JK et al. (2017) Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc?siRNA conjugates. Nucleic Acids Res. 45(19):10969-10977. doi: 10.1093/nar/gkx818
* Sehgal A et al. (2015) An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia. Nature Medicine 21(5):492-497
* Saleh AAW et al. (2014) Markers of Inflammation and Thrombophilia in Psoriasis. Med. J. Cairo Univ. 82(1):127-131
* Cubedo J et al. (2013) High-molecular-weight kininogen and the intrinsic coagulation pathway in patients with de novo acute myocardial infarction. Thromb Haemost. 110(6):1121-34.
* Yang MH et al. (2012) Activity-dependent neuroprotector homeobox protein: A candidate protein identified in serum as diagnostic biomarker for Alzheimer's disease. J Proteomics. 75(12):3617-29.
* Andersen RF et al. (2012) Plasma and urine proteomic profiles in childhood idiopathic nephrotic syndrome. Proteomics Clin Appl. 6(7-8):382-93
* Verrills NM et al. (2011) Identification of Novel Diagnostic Biomarkers for Asthma and Chronic Obstructive Pulmonary Disease. AJRCCM. doi:10.1164/rccm.201010-1623OC.
* Oberbach A et al. (2011) Combined Proteomic and Metabolomic Profiling of Serum Reveals Association of the Complement System with Obesity and Identifies Novel Markers of Body Fat Mass Changes. J Proteome Res. 10(10):4769-88
